CheckMyRecalls

Endo USA, Inc. recalls Everolimus tablets 5mg

Published
22 Oct 2025
Units affected
1,041 cartons
Agency
FDA
Country
United States

The hazard

Failed Impurities/Degradation Specifications: Out of specification for impurity IP-C.

Classification: Class III — this product is unlikely to cause health problems but breaks FDA rules (for example labeling).

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Everolimus tablets 5mg, 28 tablets (each carton contains 4 blister strips with 7 tablets each), Rx only, Manufactured by: Par Pharmaceutical Chestnut Ridge, NY 10977, NDC 49884-125-91

Brand / company
Endo USA, Inc.
Codes / lots
Lot #: 550172301, Exp. Date January 2026
Distribution
Nationwide within the United States
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 22 Oct 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.